OAK ASSOCIATES LTD /OH/ - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
OAK ASSOCIATES LTD /OH/ ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$591,128
+7.1%
61,384
+18.3%
0.05%
+11.4%
Q2 2023$551,865
-76.3%
51,867
-76.6%
0.04%
-77.0%
Q1 2023$2,327,960
-10.5%
221,289
+5.4%
0.19%
-12.4%
Q4 2022$2,601,268
+614.6%
209,949
+498.1%
0.22%
+603.2%
Q3 2022$364,00035,1000.03%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders